193 related articles for article (PubMed ID: 31556332)
21. A Post-processing framework for localized 2D MR spectroscopy in vivo.
Watanabe H; Takaya N; Mitsumori F
Magn Reson Med Sci; 2013; 12(3):215-21. PubMed ID: 23857154
[TBL] [Abstract][Full Text] [Related]
22. Proton MR spectroscopy in neonates with perinatal cerebral hypoxic-ischemic injury: metabolite peak-area ratios, relaxation times, and absolute concentrations.
Cheong JL; Cady EB; Penrice J; Wyatt JS; Cox IJ; Robertson NJ
AJNR Am J Neuroradiol; 2006 Aug; 27(7):1546-54. PubMed ID: 16908578
[TBL] [Abstract][Full Text] [Related]
23. Cerebral metabolic alterations in human immunodeficiency virus-related encephalopathy detected by proton magnetic resonance spectroscopy. Comparison between sequences using short and long echo times.
Salvan AM; Vion-Dury J; Confort-Gouny S; Nicoli F; Lamoureux S; Cozzone PJ
Invest Radiol; 1997 Aug; 32(8):485-95. PubMed ID: 9258737
[TBL] [Abstract][Full Text] [Related]
24. Role of MRSI Major Metabolite Ratios in Differentiating Between Intracerebral Ring-Enhancing Neoplastic and Non-Neoplastic Lesions, High-Grade Gliomas and Metastases, and High-Grade and Low-Grade Gliomas.
Ankush A; Sardessai S
Cureus; 2022 Nov; 14(11):e31841. PubMed ID: 36579207
[TBL] [Abstract][Full Text] [Related]
25. Impact of cerebrospinal fluid contamination on brain metabolites evaluation with 1H-MR spectroscopy: a single voxel study of the cerebellar vermis in patients with degenerative ataxias.
Guerrini L; Belli G; Mazzoni L; Foresti S; Ginestroni A; Della Nave R; Diciotti S; Mascalchi M
J Magn Reson Imaging; 2009 Jul; 30(1):11-7. PubMed ID: 19557841
[TBL] [Abstract][Full Text] [Related]
26. Improved reproducibility of MRS regional brain thermometry by 'amplitude-weighted combination'.
Cady EB; Penrice J; Robertson NJ
NMR Biomed; 2011 Aug; 24(7):865-72. PubMed ID: 21834009
[TBL] [Abstract][Full Text] [Related]
27. Metabolic changes in the normal ageing brain: consistent findings from short and long echo time proton spectroscopy.
Gruber S; Pinker K; Riederer F; Chmelík M; Stadlbauer A; Bittsanský M; Mlynárik V; Frey R; Serles W; Bodamer O; Moser E
Eur J Radiol; 2008 Nov; 68(2):320-7. PubMed ID: 17964104
[TBL] [Abstract][Full Text] [Related]
28. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors.
Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX
Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615
[TBL] [Abstract][Full Text] [Related]
29. On the relation between MR spectroscopy features and the distance to MRI-visible solid tumor in GBM patients.
Pedrosa de Barros N; Meier R; Pletscher M; Stettler S; Knecht U; Herrmann E; Schucht P; Reyes M; Gralla J; Wiest R; Slotboom J
Magn Reson Med; 2018 Dec; 80(6):2339-2355. PubMed ID: 29893995
[TBL] [Abstract][Full Text] [Related]
30. Proton magnetic resonance spectroscopy in immunocompetent patients with primary central nervous system lymphoma.
Raizer JJ; Koutcher JA; Abrey LE; Panageas KS; DeAngelis LM; Lis E; Xu S; Zakian KL
J Neurooncol; 2005 Jan; 71(2):173-80. PubMed ID: 15690135
[TBL] [Abstract][Full Text] [Related]
31. Value of single-voxel proton MR spectroscopy in temporal lobe epilepsy.
Achten E; Boon P; Van De Kerckhove T; Caemaert J; De Reuck J; Kunnen M
AJNR Am J Neuroradiol; 1997; 18(6):1131-9. PubMed ID: 9194441
[TBL] [Abstract][Full Text] [Related]
32. Axonal damage in multiple sclerosis plaques: a combined magnetic resonance imaging and 1H-magnetic resonance spectroscopy study.
Simone IL; Tortorella C; Federico F; Liguori M; Lucivero V; Giannini P; Carrara D; Bellacosa A; Livrea P
J Neurol Sci; 2001 Jan; 182(2):143-50. PubMed ID: 11137520
[TBL] [Abstract][Full Text] [Related]
33. Metabolic mapping of gliomas using hybrid MR-PET imaging: feasibility of the method and spatial distribution of metabolic changes.
Bisdas S; Ritz R; Bender B; Braun C; Pfannenberg C; Reimold M; Naegele T; Ernemann U
Invest Radiol; 2013 May; 48(5):295-301. PubMed ID: 23296081
[TBL] [Abstract][Full Text] [Related]
34. Combination of single-voxel proton MR spectroscopy and apparent diffusion coefficient calculation in the evaluation of common brain tumors.
Bulakbasi N; Kocaoglu M; Ors F; Tayfun C; Uçöz T
AJNR Am J Neuroradiol; 2003 Feb; 24(2):225-33. PubMed ID: 12591638
[TBL] [Abstract][Full Text] [Related]
35. Differentiation between high-grade glioma and metastatic brain tumor using single-voxel proton MR spectroscopy.
Ishimaru H; Morikawa M; Iwanaga S; Kaminogo M; Ochi M; Hayashi K
Eur Radiol; 2001; 11(9):1784-91. PubMed ID: 11511902
[TBL] [Abstract][Full Text] [Related]
36. Magnetic resonance spectroscopic imaging for visualization of the infiltration zone of glioma.
Stadlbauer A; Buchfelder M; Doelken MT; Hammen T; Ganslandt O
Cent Eur Neurosurg; 2011 May; 72(2):63-9. PubMed ID: 20635312
[TBL] [Abstract][Full Text] [Related]
37. White matter NAA/Cho and Cho/Cr ratios at MR spectroscopy are predictive of motor outcome in preterm infants.
Kendall GS; Melbourne A; Johnson S; Price D; Bainbridge A; Gunny R; Huertas-Ceballos A; Cady EB; Ourselin S; Marlow N; Robertson NJ
Radiology; 2014 Apr; 271(1):230-8. PubMed ID: 24475798
[TBL] [Abstract][Full Text] [Related]
38. Analysis of brain tumors using 1H magnetic resonance spectroscopy.
McBride DQ; Miller BL; Nikas DL; Buchthal S; Chang L; Chiang F; Booth RA
Surg Neurol; 1995 Aug; 44(2):137-44. PubMed ID: 7502203
[TBL] [Abstract][Full Text] [Related]
39. Quality assurance of magnetic resonance spectroscopic imaging-derived metabolic data.
Hunjan S; Adalsteinsson E; Kim DH; Harsh GR; Boyer AL; Spielman D; Xing L
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(4):1159-73. PubMed ID: 14575849
[TBL] [Abstract][Full Text] [Related]
40. Utility of proton MR spectroscopy for differentiating typical and atypical primary central nervous system lymphomas from tumefactive demyelinating lesions.
Lu SS; Kim SJ; Kim HS; Choi CG; Lim YM; Kim EJ; Kim DY; Cho SH
AJNR Am J Neuroradiol; 2014 Feb; 35(2):270-7. PubMed ID: 23928144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
